BMI View: The pharmaceutical market in Central America – consisting of the seven markets of Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and Belize – is yet to fully develop its domestic manufacturing capabilities, and therefore depends on a large amount of pharmaceutical imports. Heavy reliance on imported medicine in the region provides revenue-generating opportunities for generic drugmakers from neighbouring Latin American countries and India. We highlight that Costa Rica and Panama are the premier countries in the region where foreign drugmakers can expand their presence. Headline Expenditure Projections ? Pharmaceuticals: US$3.5bn in 2012 to US$3.6bn in 2013; +4.5% …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=110335.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/central-america-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment